no enhanced bioavailability vs epidylix though.....
so the animal studies didnt translate.
not the homerun we were looking for.
animal studies showed 1.5 -2 x bioavailability.
now we are highlighting its better than other australian products.. but no better in bioavilibility than market leader.
So whats our advantage? cheaper, easier dosing, capsule vs oil, preference from consumer? its not more effective dose for dose
Ann: EMD-RX5 demonstrates excellent safety and bioavailability, page-4
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
-0.001(2.78%) |
Mkt cap ! $14.31M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.6¢ | 3.5¢ | $20.88K | 595.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 533841 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 237157 | 1 |
View Market Depth
| Last trade - 15.49pm 15/08/2024 (20 minute delay) ? |
| EMD (ASX) Chart |